Cargando…

Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper

INTRODUCTION: The distinctive characteristics of the German health system are medical progress and financial pressure—and this is especially true of the hospitals. These challenges must be met by strategic management instruments for quality assurance, and by reducing costs. PURPOSE: This article pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Romeyke, Tobias, Stummer, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Center of Science and Education 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777053/
https://www.ncbi.nlm.nih.gov/pubmed/22980151
http://dx.doi.org/10.5539/gjhs.v4n2p50
_version_ 1782419252407435264
author Romeyke, Tobias
Stummer, Harald
author_facet Romeyke, Tobias
Stummer, Harald
author_sort Romeyke, Tobias
collection PubMed
description INTRODUCTION: The distinctive characteristics of the German health system are medical progress and financial pressure—and this is especially true of the hospitals. These challenges must be met by strategic management instruments for quality assurance, and by reducing costs. PURPOSE: This article presents the instrument “clinical pathway” (also known as “clinical treatment pathway”) and describes the possibilities it offers, both for quality assurance and risk management, and for cost reduction. The clinical pathway presented here will be that for “multimodal pain therapy”, as used in the context of acute inpatient care in Germany. METHODS: A general presentation of the risks in hospital is followed by consideration of the risks associated with core processes. A comprehensive total cost analysis is performed for those patients who meet the pathway entry criteria and who fulfil the requirements for the structure of care provided within multimodal pain therapy. DISCUSSION AND CONCLUSION: Multimodal pain therapy places high demands on the structural, procedural and outcome quality of the medical, nursing and therapeutic services provided, and these demands are reflected in high costs for the provision of this care. The treatment process involves many different professional groups. These complex interfaces can potentially generate risks, which can lead to the possibility of legal liability. A clinical pathway must structure the core process and then combine elements of quality assurance in order to optimise patient care and minimise risk. The examination of costs reveals significant potential savings (patients with clinical pathway: EUR 3086±212; patients without clinical pathway: EUR 3774±460; Mann-Whitney U test; p<0.001). For the managers of a hospital, the clinical pathway represents a strategic management instrument that can serve for continual cost control and cost reduction, and can contribute in the form of quality assurance towards a transparent provision of services.
format Online
Article
Text
id pubmed-4777053
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Canadian Center of Science and Education
record_format MEDLINE/PubMed
spelling pubmed-47770532016-04-21 Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper Romeyke, Tobias Stummer, Harald Glob J Health Sci Articles INTRODUCTION: The distinctive characteristics of the German health system are medical progress and financial pressure—and this is especially true of the hospitals. These challenges must be met by strategic management instruments for quality assurance, and by reducing costs. PURPOSE: This article presents the instrument “clinical pathway” (also known as “clinical treatment pathway”) and describes the possibilities it offers, both for quality assurance and risk management, and for cost reduction. The clinical pathway presented here will be that for “multimodal pain therapy”, as used in the context of acute inpatient care in Germany. METHODS: A general presentation of the risks in hospital is followed by consideration of the risks associated with core processes. A comprehensive total cost analysis is performed for those patients who meet the pathway entry criteria and who fulfil the requirements for the structure of care provided within multimodal pain therapy. DISCUSSION AND CONCLUSION: Multimodal pain therapy places high demands on the structural, procedural and outcome quality of the medical, nursing and therapeutic services provided, and these demands are reflected in high costs for the provision of this care. The treatment process involves many different professional groups. These complex interfaces can potentially generate risks, which can lead to the possibility of legal liability. A clinical pathway must structure the core process and then combine elements of quality assurance in order to optimise patient care and minimise risk. The examination of costs reveals significant potential savings (patients with clinical pathway: EUR 3086±212; patients without clinical pathway: EUR 3774±460; Mann-Whitney U test; p<0.001). For the managers of a hospital, the clinical pathway represents a strategic management instrument that can serve for continual cost control and cost reduction, and can contribute in the form of quality assurance towards a transparent provision of services. Canadian Center of Science and Education 2012-03 2012-03-01 /pmc/articles/PMC4777053/ /pubmed/22980151 http://dx.doi.org/10.5539/gjhs.v4n2p50 Text en Copyright: © Canadian Center of Science and Education http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Articles
Romeyke, Tobias
Stummer, Harald
Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper
title Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper
title_full Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper
title_fullStr Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper
title_full_unstemmed Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper
title_short Clinical Pathways as Instruments for Risk and Cost Management in Hospitals - A Discussion Paper
title_sort clinical pathways as instruments for risk and cost management in hospitals - a discussion paper
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777053/
https://www.ncbi.nlm.nih.gov/pubmed/22980151
http://dx.doi.org/10.5539/gjhs.v4n2p50
work_keys_str_mv AT romeyketobias clinicalpathwaysasinstrumentsforriskandcostmanagementinhospitalsadiscussionpaper
AT stummerharald clinicalpathwaysasinstrumentsforriskandcostmanagementinhospitalsadiscussionpaper